VaramirStart free · no cardSign in

IONS relationship map

IONS

Ionis Pharmaceuticals Inc

Overview

Supply chain

SEC EDGAR · Mar 5 '26
Sources
IONS sells to Healthcare · 5
ALNY
2°BX Bodyguard Royaltiesunlisted
2°Rocheunlisted
2°NVS
MGX
2°Acuitas Therapeuticsunlisted
AstraZenecaunlisted
Bicycle Therapeuticsunlisted
Biogenunlisted
Cold Spring Harbor Laboratoryunlisted
Icon Clinical Researchunlisted
Medpaceunlisted
Metagenomiunlisted
Parexel Internationalunlisted
Syneos Healthunlisted
Thermo Fisher Scientificunlisted
University of Massachusettsunlisted
Vect-Horusunlisted
← Buys from
IONS
Healthcare5 · open
BIIB
2°RNAC
2°STOK
2°KNSA
PRAX
2°UCB Biopharma SRLunlisted
2°RogConunlisted
2°Tenacia Biotechnology (Shanghai)unlisted
PTCT
2°Royalty Pharma Investments 2019 ICAV (Royalty Pharma)unlisted
2°Akcea Therapeuticsunlisted
2°Rocheunlisted
Otsuka Pharmaceuticalunlisted
Swedish Orphan Biovitrum ABunlisted
Industrials & materials5 ›
Sells to →
ALNY
2°BX Bodyguard Royaltiesunlisted
2°Rocheunlisted
2°NVS
MGX
2°Acuitas Therapeuticsunlisted
AstraZenecaunlisted
Bicycle Therapeuticsunlisted
Biogenunlisted
Cold Spring Harbor Laboratoryunlisted
Icon Clinical Researchunlisted
Medpaceunlisted
Metagenomiunlisted
Parexel Internationalunlisted
Syneos Healthunlisted
Thermo Fisher Scientificunlisted
University of Massachusettsunlisted
Vect-Horusunlisted
← Buys from
IONS
BIIB
2°RNAC
2°STOK
2°KNSA
PRAX
2°UCB Biopharma SRLunlisted
2°RogConunlisted
2°Tenacia Biotechnology (Shanghai)unlisted
PTCT
2°Royalty Pharma Investments 2019 ICAV (Royalty Pharma)unlisted
2°Akcea Therapeuticsunlisted
2°Rocheunlisted
Otsuka Pharmaceuticalunlisted
Swedish Orphan Biovitrum ABunlisted
Sells to →
Suppliers14Customers5
ALNY
MGX
AstraZenecaunlisted
Bicycle Therapeuticsunlisted
Biogenunlisted
Cold Spring Harbor Laboratoryunlisted
Icon Clinical Researchunlisted
Medpaceunlisted
IONS
BIIB
PRAX
PTCT
Otsuka Pharmaceuticalunlisted
Swedish Orphan Biovitrum ABunlisted
+6 more
suppliercustomerunlisted2°second-degree (Extended)
sector group
Thick line = filed share ·Moves · 20:05 ETSources